The history of copyright's flagship drug presents a interesting case for observers in the pharmaceutical sector. While initially a blockbuster success, generating billions, the intellectual property expiration and the subsequent entry of off-brand alternatives have significantly impacted revenue. This poses questions about the future viability o… Read More